Notice2023-25326
Agency Information Collection Activities; Proposed eCollection eComments Requested; Import/Export Declaration for List I and List II Chemical
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 16, 2023
Issuing agencies
Justice Department
Abstract
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on September 11, 2023, allowing for a 60-day comment period.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 220 (Thursday, November 16, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 220 (Thursday, November 16, 2023)]
[Notices]
[Pages 78787-78788]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-25326]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0023]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Import/Export Declaration for List I and List II
Chemical
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice (DOJ), will be submitting the following information collection
request to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act of 1995. This
proposed information collection was previously published in the Federal
Register on September 11, 2023, allowing for a 60-day comment period.
DATES: Comments are encouraged and will be accepted for 30 days until
December 18, 2023.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact Scott A. Brinks,
Regulatory Drafting and Policy Support Section,
[[Page 78788]]
Drug Enforcement Administration; Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152; Telephone: (571) 362-3261, email:
<a href="/cdn-cgi/l/email-protection#becdddd1caca90df90dcccd7d0d5cdfedadbdf90d9d1c8"><span class="__cf_email__" data-cfemail="addecec2d9d983cc83cfdfc4c3c6deedc9c8cc83cac2db">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 1117-0023. This information collection request
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view
Department of Justice, information collections currently under review
by OMB.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Import/Export Declaration for List
I and List II Chemicals.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: DEA Forms: 486, 486A.
The applicable component within the Department of Justice is the Drug
Enforcement Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract: Affected public (Primary): Business or other
for-profit. Affected public (Other): Not-for-profit institutions;
Federal, State, local, and tribal governments.
Abstract: Section 1018 of the Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 971) and Title 21 Code of Federal
Regulations (21 CFR) Part 1313 require any persons who import, export,
or conduct international transactions involving list I and list II
chemicals are required to establish a system of recordkeeping and
report certain information regarding those transactions to DEA. The
chemicals subject to control are used in the clandestine manufacture of
controlled substances. The reports of domestic, import, and export
regulated transactions in listed chemicals are submitted electronically
through the Diversion Control Division secure network application. Any
person who desires to import non-narcotic substances in schedules III,
IV, and V must electronically file their return information. Any person
who desires to export non-narcotic substances in schedules III and IV
and any other substance in schedule V is also required to
electronically file a controlled substances import declaration/
controlled substance export invoice.
5. Obligation to Respond: Mandatory per 21 CFR 1313.
6. Total Estimated Number of Respondents: 631.
7. Estimated Time per Respondent: 11 minutes for DEA-486 Import,
DEA-486 International, and DEA-486A Import, and 12 minutes for DEA-486
Export.
8. Frequency: 1 for DEA-486 Import and DEA-486A Import, 4 for DEA-
486 International, and 77 for DEA-486 Export.
9. Total Estimated Annual Time Burden: Ex: 4,134 hours.
10. Total Estimated Annual Other Costs Burden: $0.
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.
Dated: November 7, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2023-25326 Filed 11-15-23; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 16, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.